All filters
Slidesets
DDI’s in Aging HIV infected Patients- Alice Pau, PharmD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Slidesets
Long Acting Antivirals: Advanced drug delivery- Mark Milad, PharmD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Slidesets
DDI’s in Aging HCV infected Patients- Elise Smolders, MSc
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Slidesets
O_14: Pharmacokinetics of Co-encapsulated Truvada® with Ingestible Sensor to Assess Adherence- Nathan Hanan
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Slidesets
O_16: A mathematical model that predicts virological failure and elucidates the impact of lymph node drug penetration- Steven Sanche
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Slidesets
O_15: Identification of long-acting NRTI candidates through in silico modelling- Marco Siccardi, PhD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Slidesets
O_17: Early Safety, Tolerability, and Pharmacokinetic Profile of GSK2838232, a Novel 2nd Generation HIV Maturation Inhibitor, as Assessed in Healthy Subjects- Mark Johnson, MD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Slidesets
O_18: Drug-drug interactions of Glecaprevir and Pibrentasvir with Pravastatin, Rosuvastatin, or Dabigatran etexilater- Matthew Kosloski
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Slidesets
O_19: Influences on Pharmacokinetics of ledipasvir, sofosbuvir and GS-331007 in patients with decompensated cirrhosis – results from the UK Expanded Access programme- Omar Elsherif
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Slidesets
O_20: Evaluation of Drug-Drug Interactions between Sofosbuvir/Velpatasvir/Voxilaprevir and Boosted or Unboosted HIV Antiretroviral Regimens- Kimberly Garrison
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Slidesets
O_21: The Potential Role of PK-Based Drug Interactions in FAERS-Reported Rhabdomyolysis Cases in Patients Receiving a DAA Regimen and a Statin- Su-Young Choi, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Slidesets
Pro Standpoint- Nancy Reau, MD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Slidesets
Con Standpoint- Jürgen Rockstroh, MD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Slidesets
Janssen: Influenza- Thomas Kakuda, PharmD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Slidesets
Gilead: RSV - Erik Mogalian
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Slidesets
Merck: CMV - Cyrus Badshah, MD, PhD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Slidesets
Clinical Implications of Cabotegravir Plasma Levels - Charles Flexner, MD
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Slidesets
DDIs Relevant for COVID-19 Therapeutic Agents & Implementation Challenges - Fiona Marra, MPharm, MSc
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Slidesets
Emerging Strategies for Treating and Preventing Monkeypox 2022 - Ruth Byrne, MD
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Slidesets
Long-acting Cabotegravir Pharmacokinetics With and Without Oral Lead-in for HIV PrEP - Kelong Han
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Slidesets
The Non-adherent Patient A Good or Bad Candidate for CAB+RPV - Jose Castillo-Mancilla, MD
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Slidesets
CabotegravirRilpivirine Failures Despite Adherence Slides - Jose Castillo-Mancilla, MD
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Slidesets
Deep Learning Ensemble Classifier to Predict Drug-Drug Interaction - Thao Pham
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Slidesets
Islatravir Toxicity Slides - Charles Flexner, MD
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022